Polylysine modification of adenoviral fiber protein enhances muscle cell transduction

Human Gene Therapy

Volumn 10, Issue 10, 1999, Pages 1633-1640

  Bouri, Khaled ^a   Feero, W Greg ^b   Myerburg, Mike M ^a   Wickham, Thomas J ^c   Kovesdi, Imre ^c   Huffman, Eric P ^a,b   Clemens, Paula R ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c GENVEC INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS VECTOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DUCHENNE MUSCULAR DYSTROPHY; GENE TARGETING; GENETIC TRANSDUCTION; MUSCLE CELL; MYOBLAST; MYOTUBE; NONHUMAN; SKELETAL MUSCLE; TISSUE SPECIFICITY;

ADENOVIRUSES, HUMAN; ANIMALS; CAPSID; CAPSID PROTEINS; CELL LINE; CELL TRANSFORMATION, VIRAL; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; MALE; MICE; MUSCLE, SKELETAL; POLYLYSINE;

EID: 0033166881     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430349950017635     Document Type: Article

References (27)

1. ACSADI, G., JANI, A., HUARD, J., BLASCHUK, K., MASSIE, B., HOLLAND, P., LOCHMULLER, H., and KARPATI, G. (1994a). Cultured human myoblasts and myotubes show markedly different transducibility by replication defective adenovirus recombinants. Gene Ther. 1, 338-340.
2. ACSADI, G., JANI, A., MASSIE, B., SIMONEAU, M., HOLLAND, P., BLASCHUK, K., and KARPATI, G. (1994b). A differential efficiency of adenovirus-mediated in vivo gene transfer into skeletal muscle cells of different maturity. Hum. Mol. Genet. 3, 579-584.
3. ACSADI, G., LOCHMULLER, H., JANI, A., HUARD, J., MASSIE, B., PRESCOTT, S., SIMONEAU, M., PETROF, B.J., and KARPATI, G. (1996). Dystrophin expression in muscle of mdx mice after adenovirus-mediated in vivo gene transfer. Hum. Gene Ther. 7, 129-140.
4. BERGELSON, J.M., CUNNINGHAM, J.A., DROGUETT, G., KURTJONES, E.A., KRITHIVAS, A., HONG, J.S., HORWITZ, M.S., CROWELL, R.L., and FINBERG, R.W. (1997). Isolation of a common receptor for Coxsackie B viruses and adenovirus 2 and 5. Science 275, 1320-1323.
5. BRANDAN, E., CAREY, D., LARRAIN, J., MELO, F., and CAMPOS, A. (1996). Synthesis and processing of glypican during differentiation of skeletal muscle cells. Eur. J. Cell Biol. 71, 170-176.
6. CAMPOS, A., NUNEZ, R., KOENIG, C., CAREY, D., and BRANDAN, E. (1993). A lipid-anchored heparan sulfate proteoglycan is present in the surface of differentiated skeletal muscle cells. Eur. J. Biochem. 216, 587-595.
7. CLEMENS, P.R., KOCHANECK, S., SUNADA, Y., CHAN, S., CHEN. H.-H., CAMPBELL, K.P., and CASKEY, C.T. (1996). In vivo muscle gene transfer of full-length dystrophin with an adenoviral vector that lacks all viral genes. Gene Ther. 3, 965-972.
8. DOUGLAS, J.T., ROGERS, B.E., ROSENFELD, M.E., MICHAEL, S.I., FENG, M., and CURIEL, D.T. (1996). Targeted gene delivery by tropism-modified adenoviral vectors. Nature Biotechnol. 14, 1574-1578.
9. FEERO, W.G., ROSENBLATT, J.D., HUARD, J., WATKINS, S.C., EPPERLY, M., CLEMENS, P.R., KOCHANEK, S., GLORIOSO, J.C., PARTRIDGE, T.A., and HOFFMAN, E.P. (1997). Viral gene delivery to skeletal muscle: Insights on maturation-dependent loss of fiber infectivity for adenovirus and herpes simplex type 1 viral vectors. Hum. Gene Ther. 8, 371-380.
10. HUARD, J., LOCHMULLER, H., ACSADI, J., JANI, A., MASSIE, B., and KARPATI, G. (1995a). The route of administration is a major determinant of the transduction efficiency of rat tissue by adenoviral recombinants. Gene Ther. 2, 107-115.
11. HUARD, J., LOCHMULLER, H., ACSADI, G., JANI, A., HOLLAND, P., GUERIN, C., MASSIE, B., and KARPATI, G. (1995b). Differential short-term transduction efficiency of adult versus newborn mouse tissues by adenovirus recombinants. Exp. Mol. Pathol. 62, 131-143.
12. KRASNYKH, V.N., MIKHEEVA, G.V., DOUGLAS, J.T., and CURIEL, D. (1996). Generation of recombinant adenovirus vectors with modified fibers for altering viral tropism. J. Virol. 70, 6839-6846.
13. MACGREGOR, G.R., MOGG, A.E., BURKE, J.F., and CASKEY, C.T. (1987). Histochemical staining of clonal mammalian cell lines expressing E. coli β-galactosidase indicates heterogeneous expression of the bacterial gene. Somat. Cell Mol. Genet. 13, 253-265.
14. MANIATIS, T., FRITSCH, E.F., and SAMBROOK, J. (1989). Molecular Cloning: A Laboratory Manual, 2nd Ed. (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY) pp. 16.59-16.67.
15. MITTEREDER, N., MARCH, K.L., and TRAPNELL, B.C. (1996). Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy. J. Virol. 70, 7498-7509.
16. MORGAN, J.E., BEAUCHAMP, J.R., PAGEL, C.N., PECKHAM, M., ATALIOTIS, P., JAT, P.S., NOBLE, M.D., FARMER, K., and PARTRIDGE, T.A. (1994). Myogenic cell lines derived from transgenic mice carrying a thermolabile T antigen: A model system for the derivation of tissue-specific and mutation-specific cell lines. Dev. Biol. 162, 486-498.
17. RAGOT, T., VINCENT, N., CHAFEY, P., VIGNE, E., GILGENKRANTZ, H., COUTON, D., CARTAUD, J., BRIAND, P., KAPLAN, J.-C. PERRICAUDET, M., and KAHN, A. (1993). Efficient adenovirus-mediated transfer of a human minidystrophin gene to skeletal muscle of mdx mice. Nature (London) 361, 647-650.
18. RANDO, T.A., and BLAU, H.M. (1994). Primary mouse myoblasts purification, characterization, and transplantation for cell-mediated gene therapy. J. Cell Biol. 125, 1275-1287.
19. ROSENBLATT, J.D., LUNT, A., PARRY, D.J., and PARTRIDGE, T.A. (1995). Culturing of satellite cells from living single muscle fiber explants. In Vitro Dev. Biol. 31, 773-779.
20. TOMKO, P.R., XU, R., and PHTLIPSON, L. (1997). HCAR and MCAR: The human and mouse cellular receptors for subgroup C adenoviruses and group B Coxackieviruses. Proc. Natl. Acad. Sci. U.S.A. 94, 3352-3356.
21. TRAPNELL, B., and GORZIGLIA, M. (1994). Gene therapy using adenoviral vectors. Curr. Opin. Biotechnol. 5, 617-625.
22. VINCENT, N., RAGOT, T., GILGENKRANTZ, H., COUTON, D., CHAFEY, P., GREGOIRE, A., BRIAND, P., KAPLAN, J.-C., KAHN, A., and PERRICAUDET, M. (1993). Long-term correction of mouse dystrophic degeneration by adenovirus-mediated transfer of a minidystrophin gene. Nature Genet. 5, 130-134.
23. WATKINS, S.J., MESYANZHINOV, V.V., KUROCHKINA, L.P., and HAWKINS, R.E. (1997). The "adenobody" approach to viral targeting: Specific and enhanced adenoviral gene delivery. Gene Ther. 4, 1004-1012.
24. 5 promote adenovirus internalization but not virus attachment. Cell 73, 309-319.
25. WICKHAM, T.J., SEGAL, D.M., ROELVINK, P.W., CARRION, M.E., LIZONOVA, A., LEE, G.M., and KOVESDI, I. (1996). Targeted adenovirus gene transfer to endothelial and smooth muscle cells by using bispecific antibodies. J. Virol. 70, 6831-6838.
26. WICKHAM, T.J., TZENG, E., SHEARS, II, L., ROELVINK, P., LI, Y., LEE, G., BROUGH, D., LIZONOVA, A., and KOVESDI, I. (1997). Increased in vitro and in vivo gene transfer by adenovirus vectors containing chimeric fiber proteins. J. Virol. 71, 8221-8229.
27. YANG, L., LOCHMULLER, H., LUO, J., MASSIE, B., NALBANTOGLU, J., KARPATI, G., and PETROF, B.J. (1998). Adenovirus-mediated dystrophin minigene transfer improves muscle strength in adult dystrophic (MDX) mice. Gene Ther. 5, 369-379.